Sort
10,766 grants matching “checkpoint inhibitor”
(PQ6): Is Adrenergic Stress-induced Immune Suppression at the Crossroads of Circadian Rhythm Disruption and Cancer?
$181,227Elizabeth Repasky · Roswell Park Cancer Institute Corp · R21 · FY2019 · CA
Preclinical assessment of efficacy and tumor microenvironment alterations by PPRX-1701 in glioblastoma
$181,142Sean Edward Lawler · Brown University · R21 · FY2024 · CA
Identification of Novel Regulators of Natural Killer Cell Activity
$180,970Dan S Kaufman · University Of California, San Diego · R21 · FY2022 · CA
Serial Ultrasound to Detect Early Response to Immunotherapy in Metastatic RCC
$180,888Alice Chen Fan · Stanford University · R21 · FY2022 · CA
Designed Inhibitors of Pin1 in Mitosis
$180,726Felicia A Etzkorn · Virginia Polytechnic Inst And St Univ · R01 · FY2009 · CA
A Novel Paradigm for the Development of a Peptide Vaccine to Treat KRAS Mutant Cancers
$180,637Albert J. Wong · Stanford University · R21 · FY2022 · CA
Lectikines for Immunotherapy against Ovarian Cancer
$180,478Nobuyuki Matoba · University Of Louisville · R21 · FY2024 · CA
A novel gene therapy approach targeting STING-silenced cold tumors
$180,425Jianxin You · University Of Pennsylvania · R21 · FY2024 · CA
MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer
$180,136Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Discovery of PD-1/PDL-1 inhibitors from marine microbial natural products
$180,120William Fenical · University Of California, San Diego · R01 · FY2024 · CA
Exploration of the immunosuppressive function of RBMS3/PRRX1 axis in TNBC
$179,988Guojun Wu · Wayne State University · R21 · FY2023 · CA
Quantitative evaluation of focused ultrasound thermal therapy on immunogenic cell death in breast cancer
$179,988Allison Payne · University Of Utah · R21 · FY2024 · CA
Improving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibition
$179,849Maria De Los Angeles Lopez-Olivo · University Of Tx Md Anderson Can Ctr · K08 · FY2020 · CA
Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic Cancer
$179,834Neeha Zaidi · Johns Hopkins University · K08 · FY2025 · CA
Cancer therapy with a combination of oncolytic bacteria and virus to enhance targeted cell killing and anti-tumor immune responses
$179,825Wei Kong · Arizona State University-Tempe Campus · R21 · FY2022 · CA
Exploiting the immune microenvironment for radiotargeted destruction of leptomeningeal metastases
$179,438Radu Minea · University Of Southern California · R21 · FY2018 · CA
Noninvasive monitoring of therapeutic response to immune checkpoint inhibitors using circulating exosomes in non-small cell lung cancer
$179,403Sylvia Daunert · University Of Miami School Of Medicine · R21 · FY2023 · CA
Aptamer mediated silencing of the spliceosome machinery to increase the immunogenicity of metastatic breast cancer
$179,403Paolo Serafini · University Of Miami School Of Medicine · R21 · FY2021 · CA
Functional study of C53 protein as a novel regulator of checkpoint kinases
$179,401Honglin Li · Lurie Children'S Hospital Of Chicago · R01 · FY2010 · GM
A micro-dissection platform for generating uniform-sized patient-derived tumor organoids (PDOs) for personalized cancer therapy
$179,337Sindy Kam-Yan Tang · Stanford University · R21 · FY2023 · CA
Quantitative PET Imaging for Oncologic Immunotherapy Response Prediction
$179,280Benjamin M Larimer · Massachusetts General Hospital · K99 · FY2018 · CA
Quantitative PET Imaging for Oncologic Immunotherapy Response Prediction
$179,280Benjamin M Larimer · Massachusetts General Hospital · K99 · FY2017 · CA
Linking histone demethylation and the DNA damage response.
$179,280Nima Mosammaparast · Brigham And Women'S Hospital · K08 · FY2011 · CA
Therapeutic potential of targeting DNA repair deficiency in TSC
$179,252Jeffrey Paul Mackeigan · Michigan State University · R21 · FY2022 · CA
Parametric optimization of ultrasound-mediated immuno-modulation for pancreatic cancer therapy
$179,226Paul A Dayton · Univ Of North Carolina Chapel Hill · R21 · FY2020 · CA